BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

CAPS Rating: 2 out of 5

A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.


Player Avatar mogruith (96.85) Submitted: 6/18/2010 8:45:39 AM : Outperform Start Price: $2.73 BDSI Score: +338.63

Beaten down, recent insider buying, solid balance sheet.

Featured Broker Partners